Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0618195Aexternal-prioritypatent/GB0618195D0/en
Priority claimed from GB0619090Aexternal-prioritypatent/GB0619090D0/en
Priority claimed from EP11190391.0Aexternal-prioritypatent/EP2422810B1/en
Application filed by Glaxosmithkline Biologicals S.A.filedCriticalGlaxosmithkline Biologicals S.A.
Publication of CY1115921T1publicationCriticalpatent/CY1115921T1/el
Η παρούσα εφεύρεση σχετίζεται με σκευάσματα μονοσθενούς εμβολίου γρίπης και προγράμματα εμβολιασμού για ανοσοποίηση έναντι ασθένειας γρίπης, με τη χρήση τους στην ιατρική, ιδιαίτερα με τη χρήση τους στην αύξηση ανοσοαποκρίσεων έναντι διαφόρων αντιγόνων, και με μεθόδους παρασκευής. Ειδικότερα, η εφεύρεση σχετίζεται με μονοσθενείς ανοσογόνες συνθέσεις γρίπης που περιέχουν ένα αντιγόνο γρίπης ή αντιγονικό παρασκεύασμα αυτού από ένα στέλεχος ιού γρίπης που σχετίζεται με ξέσπασμα πανδημίας ή δυνητικά σχετίζεται με ξέσπασμα πανδημίας, σε συνδυασμό με ένα ανοσοενισχυτικό γαλάκτωμα ελαίου σε νερό που περιέχει μεταβολίσιμο έλαιο, στερόλη ή τοκοφερόλη όπως αλφα τοκοφερόλη, και γαλακτωματοποιητή.
Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
composição de vacina contra influenza monovalente, kit, método para a produção de uma composição de vacina contra influenza para uma situação pandêmica ou uma situação pré-pandêmica, e, usos de um antígeno de vírus da influenza ou preparação antigênica do mesmo e de um adjuvante em emulsão óleo-em-água, de um antígeno de vírus da influenza pandêmica ou preparação antigênica do antígeno de hemaglutinina do vírus da influenza, de um vírus da influenza pandêmica ou preparação antigênica do mesmo, e de um adjuvante em emulsão óleo-em-água e de um antígeno ou preparação antigênica de uma primeira cepa de influenza
composição imunogênica, vacina, método para tratamento ou prevenção de doença, e para preparar a composição imunogênica ou vacina, uso da vacina,e, composição farmacêutica.
Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice
Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine
Adjuvanted inactivated influenza A (H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines
Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine